Medicine
Alternative & Complementary Medicine
Clinical Medicine
Traditional Chinese Medicine
Nursing & Health Professions
Health Professions
Nursing
Pharmacology
Public Health
Behavioral Sciences
Behavioral & Social Sciences
Basic Sciences
Life & Biomedical Sciences
Science
Humanities & Technology
Arts & Humanities
Medical Humanities
Technology
Platforms
 
 
Product Type
 
 
Defining Optimal Immunotherapies for Type 1
Print Page

Defining Optimal Immunotherapies for Type 1 Diabetes (Novartis Foundation Symposium 292)

Platform:
Share with Colleagues:

Submitting your cart will send your request to an Ovid Rep only and will not cost anything (excludes OvidMD).
Do not see a "Request Info" option? That means that product is available in a Collection only, and not offered as a stand–alone product.

Promotion Code
Apply
 

Description

Collections

Details

This book is a comprehensive and up-to-date account of where we stand in immunological strategies for preventing or treating type 1 diabetes (T1D).

The book brings together contributions from the leaders in the arena of clinical immunotherapy, not limited to the diabetes field exclusively, in order to delineate a road-map that would lead to future clinical trials. It integrates information from human and animal studies and considers T1D within the broader context of autoimmune disease. The
format contains several discussions, which address specific questions and provides guidelines for future strategies and solutions for discovering a cure

  • Author/Editor: Novartis Foundation
  • ISBN/ISSN: 9780470723258
  • Specialty: Internal Medicine
  • Language:English
  • Edition: 1st
  • Pages: 222
  • Illustrations: 0
  • Year: 2008